HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Steven Hunter Simon Kendall Joel Dunning Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kunadian, B. Articles by Dunning, J. Search for Related Content PubMed PubMed Citation Articles by Kunadian, B. Articles by Dunning, J. Related Collections Valve disease Related Article

Ann Thorac Surg 2007;84:73-78
© 2007 The Society of Thoracic Surgeons

---

Original Articles: Cardiovascular

Meta-Analysis of Valve Hemodynamics and Left Ventricular Mass Regression for Stentless Versus Stented Aortic Valves

The James Cook University Hospital, Middlesbrough, United Kingdom

Accepted for publication February 14, 2007.

^_* Address correspondence to Dr Kunadian, c/o Mr Dunning, Department of Cardiothoracic Surgery, James Cook University Hospital, Middlesbrough TS4 3BW, UK (Email: babu.kunadian{at}stees.nhs.uk).

Background: Stentless aortic bioprostheses have been advocated as being superior to conventional bioprosthetic valves, with benefits including superior left ventricular mass regression and larger effective orifice area. Several high-quality randomized studies now exist on this topic, and we sought to summarize them by meta-analysis.

Methods: The literature was searched from 1995 to 2006, in MEDLINE, EMBASE, CRISP, metaRegister of Controlled Trials, and the Cochrane database. Experts were also contacted and reference lists searched. Studies were combined using the inverse variance fixed-effects model. Heterogeneity was assessed and a sensitivity analysis performed. Publication bias was also investigated.

Results: Ten studies were identified that included 919 patients in which the Freedom (Sorin Biomedica Cardio, Via Crescentino, Italy), Freestyle (Medtronic, Minneapolis, MN), Prima Plus (Edwards Life Sciences, Irvine, CA) and the Toronto and Biocor (St Jude Medical, St. Paul, MN) valves were used. The mean aortic valve gradient was lower in the stentless groups, with a weighted mean difference (WMD) of –3.57 mm Hg (95% confidence interval [CI], –4.36 to –2.78; p < 0.01). The left ventricular mass index was significantly lower in the stentless groups at 6 months (WMD, –6.42; 95% CI, –11.63 to –1.21; p = 0.02), but this improvement disappeared after 12 months (WMD, 1.19; 95% CI, –4.15 to 6.53; p = 0.66). The weighted mean increase in cross-clamp time was 23 minutes, and the increase in bypass time was 29 minutes with a stentless valve.

Conclusions: This meta-analysis showed that stentless aortic valves provide an improved level of left ventricular mass regression at 6 months, reduced aortic gradients, and an improved effective orifice area index, at the expense of a 23-minute longer cross-clamp time and a 29-minute longer bypass time.

Related Article

Invited commentary

Xu Yu Jin and Chandi Ratnatunga
Ann. Thorac. Surg. 2007 84: 78-79. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				H. Gulbins and H. Reichenspurner Which Patients Benefit From Stentless Aortic Valve Replacement? Ann. Thorac. Surg., December 1, 2009; 88(6): 2061 - 2068. [Abstract] [Full Text] [PDF]

				R. M. Suri, K. J. Zehr, T. M. Sundt III, J. A. Dearani, R. C. Daly, J. K. Oh, and H. V. Schaff Left ventricular mass regression after porcine versus bovine aortic valve replacement: a randomized comparison. Ann. Thorac. Surg., October 1, 2009; 88(4): 1232 - 1237. [Abstract] [Full Text] [PDF]

				A. Germing and A. Mugge What the cardiac surgeon needs to know prior to aortic valve surgery: impact of echocardiography Eur. J. Cardiothorac. Surg., June 1, 2009; 35(6): 960 - 964. [Abstract] [Full Text] [PDF]

				J.-L. Monin Prosthesis-patient mismatch: myth or reality? Heart, June 1, 2009; 95(11): 948 - 952. [Full Text] [PDF]

				J G Dumesnil, J Magne, N Girerd, and P Pibarot Moderate patient-prosthesis mismatch can impact on mortality after aortic valve replacement Heart, April 1, 2009; 95(7): 592 - 592. [Full Text] [PDF]

				P. Pibarot and J. G. Dumesnil Prosthetic Heart Valves: Selection of the Optimal Prosthesis and Long-Term Management Circulation, February 24, 2009; 119(7): 1034 - 1048. [Full Text] [PDF]

				M. R. Moon, J. S. Lawton, N. Moazami, N. A. Munfakh, M. K. Pasque, and R. J. Damiano Jr. POINT: Prosthesis-patient mismatch does not affect survival for patients greater than 70 years of age undergoing bioprosthetic aortic valve replacement. J. Thorac. Cardiovasc. Surg., February 1, 2009; 137(2): 278 - 283. [Abstract] [Full Text] [PDF]

				W. E. Stansfield, P. C. Charles, R.-h. Tang, M. Rojas, R. Bhati, N. C. Moss, C. Patterson, and C. H. Selzman Regression of pressure-induced left ventricular hypertrophy is characterized by a distinct gene expression profile J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 232 - 238. [Abstract] [Full Text] [PDF]

				J. Dunning, R.J. Graham, J. Thambyrajah, M.J. Stewart, S.W.H. Kendall, and S. Hunter Stentless vs. stented aortic valve bioprostheses: a prospective randomized controlled trial Eur. Heart J., October 1, 2007; 28(19): 2369 - 2374. [Abstract] [Full Text] [PDF]

				X. Y. Jin and C. Ratnatunga Invited commentary Ann. Thorac. Surg., July 1, 2007; 84(1): 78 - 79. [Full Text] [PDF]